Recently, Nahon et al[70] evaluated the effect of serum hepcidin on the long-term survival of patients with alcoholic cirrhosis by analyzing the prognosis of 237 patients with alcoholic cirrhosis. The gene discussed is HAMP; the disease is alcoholic liver cirrhosis.